Clinical TrialID 1164
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
NCT00680667
Breast Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 1164
- Evidence Id
- 1164
- Core Evidence Id
- 1164
- Source Clinical Trial Id
- 1146
- Herb2 Clinical Trial Id
- HBCT001146
- Nct Id
- NCT00680667
- Title
- Clinical Trial of Trametes Versicolor in Women With Breast Cancer
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Breast Cancer
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- BIOLOGICAL: Coriolus versicolor extract
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- Female
- Age
- Adult, Older_Adult
- Enrollment
- 11
- Outcome Measure
- Maximum tolerated dose, Up to 6 Weeks After Treatment
- Sponsor Collaborator
- Masonic Cancer Center, University of Minnesota|National Center for Complementary and Integrative Health (NCCIH)
- Funded By
- OTHER
- Location
- Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, 55455, United States|Bastyr University, Kenmore, Washington, United States
- Other Id
- 2007LS019|U19AT001998|UMN-0611M96168
- Start Date
- 2007-04
- Primary Completion Date
- 2011-04
- Completion Date
- 2011-04
- First Posted
- 2008-05-20
- Results First Posted
- Last Update Posted
- 2017-11-29
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00680667
- Title Cn
- Title En
- Clinical Trial of Trametes Versicolor in Women With Breast Cancer
- Bilingual Status
- semi_complete